CL vs SRTAW · P/E 34, rev $10.69B vs rev $248.7M
Colgate-Palmolive Company (CL) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
CL currently screens at market cap $70.88B and trailing P/E 34.3. SRTAW currently screens at market cap $0.
Not investment advice. Open the CL and SRTAW stock pages for the full models.
Not investment advice.